PROCEPT BioRobotics Corporation PRCT recently announced that it has received the FDA’s approval to commence a pivotal Investigational Device Exemption clinical trial comparing Aquablation therapy to ...
Source LinkPROCEPT BioRobotics Corporation PRCT recently announced that it has received the FDA’s approval to commence a pivotal Investigational Device Exemption clinical trial comparing Aquablation therapy to ...
Source Link
Comments